RECRUITING

Smoking Cessation Behavioral Treatment Study

Talk to us

Conditions

Tobacco Use Disorder

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the effectiveness of two behavioral interventions on smoking behavior - Mindfulness-Oriented Recovery Enhancement (MORE) and Cognitive Behavioral Therapy (CBT). MORE is a behavioral therapy that integrates mindfulness training to modify reward processes. CBT is a therapy designed to help individuals understand how their thoughts and feelings influence their behaviors.

Official Title

Neural Mechanisms Mediating Appetitive Regulation and Smoking in Nicotine Addiction

Quick Facts

Study Start:2019-12-19
Study Completion:2025-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03948893

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 and up
  2. * English fluency as demonstrated in providing informed consent and the ability to independently follow directions in completing assigned assessments and tasks
  3. * Functional vision (with corrective lenses as needed) to complete assigned assessments and tasks
  4. * Current nicotine dependent smoker with a minimum smoking history of 2 years
  5. * Interest in quitting smoking
  1. * Use of psychotropic (e.g. antiepileptic) medications in the past month
  2. * Positive urine drug screen
  3. * Presence of an untreated medical illness
  4. * Current or past psychosis
  5. * History of major neurological illness or head injury resulting in loss of consciousness
  6. * And contraindication to MRI, including claustrophobia
  7. * Among females, positive urine pregnancy test
  8. * Inability or unwillingness of subject to give informed consent

Contacts and Locations

Study Contact

Madhura Athreya, MS
CONTACT
5738822977
athreyam@health.missouri.edu
Brett Froeliger, PhD
CONTACT
5738824785
froeligerb@health.missouri.edu

Study Locations (Sites)

University of Missouri - Columbia
Columbia, Missouri, 65211
United States
Medical University of South Carolina
Charleston, South Carolina, 29425
United States

Collaborators and Investigators

Sponsor: University of Missouri-Columbia

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-12-19
Study Completion Date2025-03-31

Study Record Updates

Study Start Date2019-12-19
Study Completion Date2025-03-31

Terms related to this study

Additional Relevant MeSH Terms

  • Tobacco Use Disorder